- ICH GCP
- Yhdysvaltain kliinisten tutkimusten rekisteri
- Kliininen tutkimus NCT02693132
Comparison of Supervised and Unsupervised Physical Activity Programs During a Weight Loss Intervention for Adults (REACH)
Comparison of Supervised and Unsupervised Physical Activity Programs During a Standard Behavioral Weight Loss Intervention for Adults Who Are Overweight or Obese
Tutkimuksen yleiskatsaus
Tila
Ehdot
Yksityiskohtainen kuvaus
Approximately 69% of the U.S. adult population is overweight, defined by a body mass index (BMI) of ≥ 25.0 kg/m2, and 35% are obese (BMI ≥ 30.0 kg/m2), with the prevalence of overweight and obesity rising drastically over the past several decades. Adults who are overweight or obese are typically recommended to change lifestyle factors (e.g. diet, physical activity, etc.) to lose weight and improve health. When evaluating the effects of these lifestyle changes on weight and health in a research setting, physical activity is supervised (i.e. physical activity completed in a health-fitness facility with direct supervision from trained staff). With supervised physical activity, researchers are able to quantify the frequency, intensity, duration, and type of physical activity. Thus, supervised physical activity is considered the gold-standard when evaluating the effects of physical activity on weight and other physiological parameters. However, the results of supervised physical activity trials may not translate to clinical settings. A typical clinical approach prescribes physical activity in an unsupervised manner (i.e. physician tells patient to be more physically active or take more steps/day). Unsupervised physical activity can be done in any environment or at any time that best suits the individual. Knowing the effects of unsupervised physical activity is important because of the translation of this type of physical activity to non-research settings. Therefore, knowing the magnitude of the physiological effects of unsupervised physical activity compared to supervised physical activity at the same prescribed intensity and dose is of clinical and public health importance especially in an overweight and obese population. This study is designed to provide insight on these important research questions that can inform future research and the application to clinical, public health, and health-fitness settings.
Participants will be randomized to one of three groups: supervised physical activity prescribed in min/week (SUP-PA), unsupervised physical activity prescribed in min/week (UNSUP-PA), and unsupervised physical activity prescribed in steps/day (STEP). Participants in all three groups will participate in a behavioral weight loss intervention which includes dietary counseling and weekly group sessions during the 12-week program. SUP-PA will be prescribed 150 minutes/week of moderate-to-vigorous physical activity (MVPA) completed under direct supervision of trained staff at a designated health-fitness facility. UNSUP-PA will be prescribed a physical activity dose matched to SUP-PA. STEP will be prescribed a 10,000 step/day recommendation with 2,500 of those steps completed at a "brisk" pace. The primary aim of this study is to compare the effects of all three groups on moderate-to-vigorous physical activity (MVPA) accumulated in bouts of at least 10 minutes. The primary outcome will be assessed at baseline, week 4, week 8, and week 12. Secondary aims of this trial include comparing light intensity physical activity, sedentary time, cardiorespiratory fitness, weight, body composition, waist circumference measures, physical activity self-efficacy, blood pressure, and dietary intake across all three groups. Secondary aims will be assessed at baseline and week 12.
Opintotyyppi
Ilmoittautuminen (Todellinen)
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskelupaikat
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, Yhdysvallat, 15261
- Physical Activity and Weight Management Research Center
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Kuvaus
Inclusion Criteria:
- Male or Female
- Aged 18-55 years old
- BMI of 25.0 to <40.0 kg/m2
- Ability to provide informed consent
- Ability to provide physician's clearance to participate in a weight loss intervention
Exclusion Criteria:
- Engaging in >60 min/wk (accumulated in bouts of ≥10 minutes) of moderate-to-vigorous physical activity over the past month
- Presence of contraindications to physical activity as identified on a physical activity readiness questionnaire (PAR-Q)
- History of metabolic, cardiac, or pulmonary disease that classifies the individual as high risk by the American College of Sports Medicine (e.g., coronary heart disease, diabetes mellitus, uncontrolled hypertension, etc.)
- History of myocardial infarction, coronary bypass surgery, angioplasty, or other cardiovascular- related surgeries.
- Taking medication that may affect heart rate or blood pressure responses to physical activity
- Resting systolic blood pressure ≥150mmHg or diastolic blood pressure ≥100mmHg.
- Medication that may affect body weight/metabolism (e.g., synthroid).
- Current or previous participation in a physical activity or weight management research project in the past 6 months
- Weight loss of ≥5% or 15 pounds total of current body weight in the previous 6 months.
- Currently being treated for an eating disorder (e.g., anorexia, bulimia, etc.)
- Previously undergone bariatric surgery (e.g., lap-band, gastric bypass, etc.)
- For women, those currently pregnant, pregnant during the previous 6 months, or plan on becoming pregnant in the next 6 months
- Currently being treated for any psychological issues or problems, taking any psychotropic medications, or receiving treatment with psychotropic medications within the previous 6 months.
- Being out of town during for an extended amount of time during the weight loss intervention which may affect participation in the study
- Currently using a physical activity monitor to track activity (e.g., Jawbone UP, Fitbit, etc.)
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Hoito
- Jako: Satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Yksittäinen
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
---|---|
Kokeellinen: Supervised (SUP-PA)
Weight loss intervention that focuses on supervised physical activity and involves an energy restricted diet.
Physical activity will be supervised by trained staff.
|
Weight loss intervention that involves an energy restricted diet plus the inclusion of 150 minutes per week of supervised moderate-to-vigorous intensity physical activity.
|
Kokeellinen: Unsupervised (UNSUP-PA)
Weight loss intervention that focuses on unsupervised physical activity (identical dose to SUP-PA) and involves an energy restricted diet (identical diet to SUP-PA).
Physical activity will be self-monitored but no activity tracker will be used as an intervention tool.
|
Weight loss intervention that involves an energy restricted diet plus the inclusion of 150 minutes per week of unsupervised moderate-to-vigorous intensity physical activity.
|
Kokeellinen: Step-based (STEP)
Weight loss intervention that focuses on unsupervised physical activity prescribed as steps/day and involves an energy restricted diet (identical diet to SUP-PA and UNSUP-PA).
Physical activity will be self-monitored and a pedometer will be used to track steps/day.
|
Weight loss intervention that involves an energy restricted diet plus the inclusion of physical activity in the form of 10,000 steps/day with 2,500 "brisk" steps/day.
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
---|---|---|
Change in Moderate-to-Vigorous Physical Activity (Accumulated in Bouts of at Least 10 Minutes)
Aikaikkuna: Baseline (0 weeks), 4 Weeks, 8 Weeks, 12 Weeks
|
Measured using a wearable device and by questionnaire
|
Baseline (0 weeks), 4 Weeks, 8 Weeks, 12 Weeks
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
---|---|---|
Change in Cardiorespiratory Fitness
Aikaikkuna: Baseline (0 weeks),12 Weeks
|
Measured using a submaximal graded exercise test on a treadmill, with termination occurring at 85% of age-predicted maximal heart rate (computed at [220-age]*0.85]).
The outcome was measures as oxygen consumption (ml/kg/min) at the point of test termination.
|
Baseline (0 weeks),12 Weeks
|
Change in Body Weight
Aikaikkuna: Baseline (0 weeks),12 Weeks
|
Measured in kilograms using a digital scale
|
Baseline (0 weeks),12 Weeks
|
Change in Fat Mass
Aikaikkuna: Baseline (0 weeks),12 Weeks
|
Measured as fat mass (kg) using dual-energy x-ray absorptiometry (DXA)
|
Baseline (0 weeks),12 Weeks
|
Change in Energy Intake
Aikaikkuna: Baseline (0 weeks),12 Weeks
|
Measured as kcal/day using a questionnaire
|
Baseline (0 weeks),12 Weeks
|
Yhteistyökumppanit ja tutkijat
Sponsori
Tutkijat
- Päätutkija: Seth A Creasy, University of Pittsburgh
- Opintojen puheenjohtaja: John M Jakicic, University of Pittsburgh
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus
Ensisijainen valmistuminen (Todellinen)
Opintojen valmistuminen (Todellinen)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Arvio)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Avainsanat
Muita asiaankuuluvia MeSH-ehtoja
Muut tutkimustunnusnumerot
- PRO15110570
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .
Kliiniset tutkimukset Supervised (SUP-PA)
-
University of British ColumbiaChildren's & Women's Health Centre of British ColumbiaLopetettuSynnytykseen liittyvä brachial plexus vamma | Synnytys brachial plexus halvausKanada
-
Istituti Clinici Scientifici Maugeri SpAAktiivinen, ei rekrytointi
-
Hospices Civils de LyonInstitut National de la Santé Et de la Recherche Médicale, France; Centre... ja muut yhteistyökumppanitRekrytointiKrooninen oikea supratensoraalinen aivohalvauspotilaatRanska
-
St. Justine's HospitalRekrytointi
-
University of British ColumbiaChildren's & Women's Health Centre of British ColumbiaPeruutettuSynnytykseen liittyvä brachial plexus vamma | Synnytys brachial plexus halvaus
-
Rush University Medical CenterUniversity of Illinois at Chicago; Michigan State UniversityAktiivinen, ei rekrytointi
-
Global Alliance for TB Drug DevelopmentValmis
-
Istituti Clinici Scientifici Maugeri SpAUniversity of BolognaValmis
-
National Institute of Allergy and Infectious Diseases...Ei vielä rekrytointiaMunuaisten vajaatoiminta | TuberkuloosiYhdysvallat